Daratumumab improves the hematological response and kidney function of patients with light chain deposition disease

被引：0
作者：
Zhang Xin [1 ,2 ,3 ,4 ]
Yu Xiaojuan [1 ,2 ,3 ,4 ]
Wang Suxia [1 ,2 ,3 ,4 ,5 ]
Dong Yujun [6 ]
Zhao Minghui [1 ,2 ,3 ,4 ,7 ]
Zhou Fude [1 ,2 ,3 ,4 ]
机构：
[1] Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China
[2] Institute of Nephrology, Peking University, Beijing, China
[3] Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China
[4] Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China
[5] Laboratory of Electron Microscopy, Pathological Centre, Peking University First Hospital, Beijing, China
[6] Hematological Division, Department of Medicine, Peking University First Hospital, Beijing, China
[7] Peking-Tsinghua Center for Life Science, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing,
来源：
中华医学杂志英文版 | 2025年 / 138卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R692 [肾疾病];
学科分类号：
摘要：
<正>
引用
收藏
相关论文
共 50 条
  • [41] Light chain deposition disease (LCDD): a case series of 24 patients
    Gibbs, S. D. J.
    Pinney, J. H.
    Sattianayagam, P. T.
    Wechalekar, A. D.
    Lane, T.
    Rowczenio, D. M.
    Offer, M.
    Gilbertson, J. A.
    Hunt, T.
    Hawkins, P. N.
    Gillmore, J. D.
    Lachmann, H. J.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 185 - 186
  • [42] Cessation of Bezafibrate in patients with chronic kidney disease improves renal function
    Boris Zingerman
    Danny Ziv
    Netta Feder Krengel
    Asher Korzets
    Ilan Matok
    Scientific Reports, 10
  • [43] INTENSIVE THERAPY IN AL AMYLOIDOSIS AND LIGHT-CHAIN DEPOSITION DISEASE - RESPONSE
    LOKHORST, HM
    VERDONCK, LF
    ANNALS OF INTERNAL MEDICINE, 1995, 123 (07) : 553 - 553
  • [44] Evidence for Transition From Light Chain Deposition Disease by Immunofluorescence-Only to Classic Light Chain Deposition Disease
    Nasr, Samih H.
    Leung, Nelson
    Heybeli, Cihan
    Cornell, Lynn D.
    Alexander, Mariam Priya
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (05): : 1469 - 1474
  • [45] Changes in cardiac biomarkers with daratumumab therapy in patients with light chain amyloidosis
    Kleman, Ariel
    Leng, Siyang
    Szabo, Aniko
    Wu, Ruizhe
    Chhabra, Saurabh
    Dhakal, Binod
    Parameswaran, Hari
    Mueller, Christopher
    Bhutani, Divaya
    Sharma, Malti
    Lentzsch, Suzanne
    D'Souza, Anita
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10) : E321 - E322
  • [46] LONG-TERM FOLLOW-UP AND RESPONSE TO CHEMOTHERAPY IN PATIENTS WITH LIGHT-CHAIN DEPOSITION DISEASE
    HEILMAN, RL
    VELOSA, JA
    HOLLEY, KE
    OFFORD, KP
    KYLE, RA
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 20 (01) : 34 - 41
  • [47] Daratumumab-based front-line therapy improves treatment response and survival in patients with immunoglobulin light chain (AL) amyloidosis: the Mayo Clinic experience
    Yohannan, Binoy
    Rees, Matthew
    Gertz, Morie
    Dispenzieri, Angela
    Buadi, Francis K.
    Dingli, David
    Leung, Nelson
    Kapoor, Prashant
    Gonsalves, Wilson
    Kourelis, Taxiarchis
    Cook, Joselle M.
    Binder, Moritz
    Lacy, Martha Q.
    Hayman, Suzanne
    Hwa, Yi Lisa
    Rogers, Michelle G.
    Hobbs, Miriam
    Fonder, Amie
    Go, Ronald S.
    Warsame, Rahma
    Rajkumar, Vincent
    Kumar, Shaji
    Muchtar, Eli
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S228 - S228
  • [48] Population Pharmacokinetics and Exposure-Response Modeling of Daratumumab Subcutaneous Administration in Patients With Light-Chain Amyloidosis
    Luo, Man
    Zhu, Peijuan
    Nnane, Ivo
    Xiong, Yuan
    Merlini, Giampaolo
    Comenzo, Raymond L.
    Kastritis, Efstathios
    Wechalekar, Ashutosh D.
    Weiss, Brendan M.
    NamPhuong Tran
    Qin, Xiang
    Vermeulen, Jessica
    Sharma, Amarnath
    Sun, Yu-Nien
    Zhou, Honghui
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (05) : 656 - 669
  • [49] High dose chemotherapy in light chain or light and heavy chain deposition disease
    Royer, B
    Arnulf, B
    Martinez, F
    Roy, L
    Flageul, B
    Etienne, I
    Ronco, P
    Brouet, JC
    Fermand, JP
    KIDNEY INTERNATIONAL, 2004, 65 (02) : 642 - 648
  • [50] LIGHT CHAIN DEPOSITION DISEASE - A PATHOLOGICAL ENTITY
    HOFFMANGUILAINE, C
    NOCHY, D
    TRICOTTET, V
    MALLET, L
    BARIETY, J
    CAMILLERI, JP
    ANNALES DE PATHOLOGIE, 1984, 4 (02) : 105 - 113
12345